Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Health Care Management, Chang Gung University, Taoyuan, Taiwan.
Department of Health Care Management, Chang Gung University, Taoyuan, Taiwan.
Biomed J. 2020 Dec;43(6):476-483. doi: 10.1016/j.bj.2019.11.001. Epub 2020 Nov 24.
To evaluate the effects of prepregnancy body mass index (BMI) on pregnancy outcomes, prevalence of urinary incontinence, and quality of life.
The observational cohort included 2210 pregnant women who were divided into 4 groups according to their prepregnancy BMI: underweight (<18.5), normal weight (18.5-24.9), overweight (25-29.9), and obese (≥30). Data were analyzed for pregnancy outcomes, prevalence of urinary incontinence during pregnancy, scores of the Short Form 12 health survey (SF-12) and changes in sexual function.
Compared with normal weight, overweight and obesity were associated with advanced maternal age, low education level, multiparity, preterm delivery, cesarean section, gestational weight gain above the Institute of Medicine (IOM) guidelines, preeclampsia, gestational diabetes, macrosomia and large fetal head circumference. After adjusting for confounding factors, women with overweight and obesity were more likely to have adverse maternal outcomes (gestational weight gain above the IOM guidelines, preeclampsia and gestational diabetes) and fetal outcomes (large fetal head circumference and macrosomia) compared to normal weight women. Overweight and obese women (BMI ≥ 25) were more likely to have urinary incontinence than normal weight and underweight women. There were no significant differences in SF-12 scores among the 4 BMI groups, but more than 90% of pregnant women had reduced or no sexual activities regardless of BMI.
Maternal prepregnancy overweight and obesity are associated with greater risks of preeclampsia, gestational diabetes, macrosomia and urinary incontinence. Health care providers should inform women to start their pregnancy at a BMI in the normal weight category.
评估孕前体重指数(BMI)对妊娠结局、尿失禁患病率和生活质量的影响。
该观察性队列纳入了 2210 名孕妇,根据孕前 BMI 将其分为 4 组:消瘦组(<18.5)、正常体重组(18.5-24.9)、超重组(25-29.9)和肥胖组(≥30)。分析妊娠结局、孕期尿失禁患病率、健康调查简表 12 项(SF-12)评分和性功能变化。
与正常体重组相比,超重和肥胖组孕妇的母亲年龄较大、受教育程度较低、多胎妊娠、早产、剖宫产、孕期体重增加超过美国医学研究所(IOM)指南、子痫前期、妊娠期糖尿病、巨大儿和大头围的比例更高。调整混杂因素后,与正常体重组相比,超重和肥胖组孕妇发生不良母婴结局(孕期体重增加超过 IOM 指南、子痫前期和妊娠期糖尿病)和胎儿结局(大头围和巨大儿)的风险更高。与正常体重和消瘦组相比,超重和肥胖组(BMI≥25)孕妇发生尿失禁的可能性更高。4 组 BMI 孕妇的 SF-12 评分无显著差异,但超过 90%的孕妇无论 BMI 如何,均减少或完全没有性生活。
母亲孕前超重和肥胖与子痫前期、妊娠期糖尿病、巨大儿和尿失禁的风险增加相关。医务人员应告知女性在正常体重范围内开始妊娠。